Typical tall poppy syndrome.
However the options issue needs to be within reason. The pro's need to outweigh the cons with regard to shareholders - funding the company vs dilution.
Ann: Notice of Meeting, Executive Incentive Plan and option issue, page-11
-
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add FAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
-0.005(1.06%) |
Mkt cap ! $42.97M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 47.0¢ | 45.5¢ | $31.34K | 67.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3338 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 199900 | 2 |
View Market Depth
| Last trade - 15.59pm 13/09/2024 (20 minute delay) ? |
| FAR (ASX) Chart |